AI Assessment of Low-Gradient Aortic Stenosis Severity Based on Echocardiography

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

August 18, 2025

Primary Completion Date

August 18, 2026

Study Completion Date

August 18, 2026

Conditions
Low-gradient Aortic StenosisAortic Stenosis
Interventions
DIAGNOSTIC_TEST

AI diagnostic test for severe low-gradient aortic stenosis

All participants will undergo standard transthoracic echocardiography performed for clinical indications. Echocardiographic images will be analyzed both by experienced physicians and by the investigational AI model. Additional diagnostic tests (such as cardiac CT, low-dose dobutamine stress echocardiography or transesophageal echocardiography) may be performed if clinically indicated, according to current guideline recommendations. The AI-derived results will not influence clinical decision-making.

Trial Locations (1)

Unknown

Department of Valvular Heart Disease, National Institute of Cardiology, Warsaw, Poland, Warsaw

All Listed Sponsors
collaborator

The Institute of Bioorganic Chemistry, Polish Academy of Sciences

UNKNOWN

collaborator

Poznan Supercomputing and Networking Center, Polish Academy of Sciences, Poznan, Poland

UNKNOWN

lead

National Institute of Cardiology, Warsaw, Poland

OTHER

NCT07144189 - AI Assessment of Low-Gradient Aortic Stenosis Severity Based on Echocardiography | Biotech Hunter | Biotech Hunter